Cargando…
Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2
BACKGROUND: Non-pharmaceutical measures to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be carefully tuned as they can impose a heavy social and economic burden. To quantify and possibly tune the efficacy of these anti-SARS-CoV-2 measures, we have devised...
Autores principales: | Kitanovski, Simo, Horemheb-Rubio, Gibran, Adams, Ortwin, Gärtner, Barbara, Lengauer, Thomas, Hoffmann, Daniel, Kaiser, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215636/ https://www.ncbi.nlm.nih.gov/pubmed/34154549 http://dx.doi.org/10.1186/s12889-021-11178-w |
Ejemplares similares
-
Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe
por: Horemheb-Rubio, Gibran, et al.
Publicado: (2022) -
Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021) -
Safe and effective pool testing for SARS-CoV-2 detection
por: Wunsch, Marie, et al.
Publicado: (2021) -
intePareto: an R package for integrative analyses of RNA-Seq and ChIP-Seq data
por: Cao, Yingying, et al.
Publicado: (2020) -
Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
por: Vanderwall, Elizabeth R., et al.
Publicado: (2022)